about
Differences in presentation of symptoms between women and men with intermittent claudication.Factors associated with good self-rated health and quality of life in subjects with self-reported COPD.The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease.A heel cup improves the function of the heel pad in Sever's injury: effects on heel pad thickness, peak pressure and pain.Sever's injury; treat it with a heel cup: a randomized, crossover study with two insole alternatives.Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study.Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37,843 individuals.Extended pelvic lymph-node dissection and radiotherapy with curative intent in high-risk lymph-node-positive prostate cancer: a possible curative strategy?The SELMA study: a birth cohort study in Sweden following more than 2000 mother-child pairs.Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.E/a´ ratio a simple detector of left ventricular dysfunction in patients with decreased ejection fraction.Carbon Dioxide and Glucose Affect Electrocortical Background in Extremely Preterm InfantsAsymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?Sever's injury: a clinical diagnosisSialic acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort: the Värmland surveyThe a´ velocity in the tissue Doppler predicts S/D ratio <1 in patients with a normal ejection fraction
P50
Q33947273-1B8E026E-643E-479D-BEF0-969DE755F484Q35508598-7D4D66D0-D392-408A-B947-18F60D823328Q38700069-AF04CBBC-DCFF-4A21-9925-BE4E94AAE067Q39269229-D7C3C7D2-7ECB-4650-8EA4-D12F6CC4D97DQ39282060-F74ACD82-62CE-4972-BDAF-ED2288CD04A0Q43162994-2AF1B954-8C06-4492-92F0-6A0E13266384Q43997599-D23192CD-29D3-4B53-A193-A9ED9B7FD918Q48208757-6B6AF406-0335-4255-80FD-A61566743D42Q51334446-54D0CE5E-A261-4D4F-94F7-DEB412968961Q51747905-551254AA-20A6-41B8-958D-038CD153FCDFQ52752022-EF98288D-97B2-4514-A359-3F0137A3867AQ59153710-ADD340DD-5232-41E6-854A-63BBAD3EE8E8Q83750064-9E62C157-DC40-47BE-AD66-4E7E1C0A5703Q86047720-AE095F5B-6DB6-4ADB-AB20-9B7753D3BDAFQ88221303-9AB308AF-CBA9-4F89-BF91-82D540CD6BB6Q88349750-15013CFF-AE10-4133-B2D0-AA73CAB26171
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fredrik Lundin
@ast
Fredrik Lundin
@en
Fredrik Lundin
@es
Fredrik Lundin
@nl
Fredrik Lundin
@sl
type
label
Fredrik Lundin
@ast
Fredrik Lundin
@en
Fredrik Lundin
@es
Fredrik Lundin
@nl
Fredrik Lundin
@sl
prefLabel
Fredrik Lundin
@ast
Fredrik Lundin
@en
Fredrik Lundin
@es
Fredrik Lundin
@nl
Fredrik Lundin
@sl
P106
P31
P496
0000-0002-7347-8393